Evaluation of the evidence on staging imaging for detection of asymptomatic distant metastases in newly diagnosed breast cancer

Breast

Volumn 21, Issue 2, 2012, Pages 112-123

  Brennan, M E ^a   Houssami, N ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Breast cancer; Distant metastases; Imaging; Sensitivity and specificity; Staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODINE 123;

ADVANCED CANCER; BONE METASTASIS; BONE SCINTISCANNING; BREAST CANCER; CANCER INCIDENCE; CANCER STAGING; CLINICAL EVALUATION; CLINICAL FEATURE; COMPARATIVE EFFECTIVENESS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISTANT METASTASIS; EARLY CANCER; EVIDENCE BASED MEDICINE; HUMAN; INTERMETHOD COMPARISON; LIVER EXAMINATION; LIVER METASTASIS; LUNG METASTASIS; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMATIC REVIEW; THORAX RADIOGRAPHY;

EID: 84858748823     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2011.10.005     Document Type: Review

References (36)

1. Carlson R.W., Allred D.C., Anderson B.O., Burstein H.J., Carter W.B., Edge S.B., et al. Invasive breast cancer: NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network 2011, 9(2):136-222.
2. National Breast Cancer Centre (NBCC) Clinical practice guidelines for the management of early breast cancer 2001, National Breast Cancer Centre, Camperdown. 2nd ed.
3. Scottish Intercollegiate Guidelines Network Management of breast cancer in women - a national clinical guideline 2005, Scottish intercollegiate guidelines Network, Edinburgh.
4. Cancer Care Ontario Baseline staging tests in primary breast cancer practice guideline report # 1-14 2003, http://www.cancercare.on.ca.
5. Ciatto S., Pacini P., Azzini V., Neri A., Jannini A., Gosso P., et al. Preoperative staging of primary breast cancer. A multicentric study. Cancer 1988, 61(5):1038-1040.
6. Ravaioli A., Pasini G., Polselli A., Papi M., Tassinari D., Arcangeli V., et al. Staging of breast cancer: new recommended standard procedure. Breast Cancer Research and Treatment 2002, 72(1):53-60.
7. SAS Version 9.2. NC, USA.
8. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., G√∏tzsche P.C., Ioannidis J.P.A., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009, 6(7):e1000100.
9. Abe K., Sasaki M., Kuwabara Y., Koga H., Baba S., Hayashi K., et al. Comparison of FDG-PET with TC-HMDP scntigraphy for the detection of bone metastases in patients with breast cancer. Annals of Nuclear Medicine 2005, 19(7):573-579.
10. Alberini J.L., Lerebours F., Wartski M., Fourme E., Le Stanc E., Gontier E., et al. 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer. Cancer 2009, 115(21):5038-5047.
11. Barrett T., Bowden D.J., Greenberg D.C., Brown C.H., Wishart G.C., Britton P.D. Radiological staging in breast cancer: Which asymptomatic patients to image and how. British Journal of Cancer 2009, 101:1522-1528.
12. Barry M., Thornton F., Murphy M., Younis F., Watson R. The value of metastatic screening in early primary breast cancer. Irish Journal of Medical Science 1999, 168(4):248-250.
13. Buchmann I., Riedmüller K., Hoffner S., Mack U., Aulmann S., Haberkorn U. Comparison of 99mtechnetium-pertechnetate and 123iodide SPECT with FDG-PET in patients suspicious for breast cancer. Cancer Biotherapy & Radiopharmaceuticals 2007, 22(6):779-789.
14. Carkaci S., Macapinlac H.A., Cristofanilli M., Mawlawi O., Rohren E., Gonzalez Angulo A.M., et al. Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data. Journal of Nuclear Medicine 2009, 50:231-238.
15. Çermik T., Mavi A., Basu S., Alavi A. Impact of fdg pet on the preoperative staging of newly diagnosed breast cancer. European Journal of Nuclear Medicine and Molecular Imaging 2008, 35(3):475-483.
16. Dillman R.O., Chico S. Radiologic tests after a new diagnosis of breast cancer. Effective Clinical Practice 2000, 3(1):1-6.
17. Fuster D., Duch J., Paredes P., Velasco M., Munoz M., Santamaria G., et al. Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures. Journal of Clinical Oncology 2008, 26(29):4746-4751.
18. Groheux D., Moretti J.-L., Baillet G., Espie M., Giacchetti S., Hindie E., et al. Effect of (18)F-FDG PET/CT imaging in patients with clinical stage II and III breast cancer. International Journal of Radiation Oncology Biology Physics 2008, 71(3):695-704.
19. Heusner T.A., Kuemmel S., Umutlu L., Koeninger A., Freudenberg L.S., Hauth E.A.M., et al. Breast cancer staging in a single session: whole-body PET/CT mammography. Journal of Nuclear Medicine 2008, 49:1215-1222.
20. Kasem A.R., Desai A., Daniell S., Sinha P. Bone scan and liver ultrasound scan in the preoperative staging for primary breast cancer. The Breast Journal 2006, 12(6):544-548.
21. Kim H., Han W., Moon H.-G., Min J., Ahn S.-K., Kim T.-Y., et al. The value of preoperative staging chest computed tomography to detect asymptomatic lung and liver metastasis in patients with primary breast carcinoma. Breast Cancer Research and Treatment 2011, 126(3):637-641.
22. Koizumi M., Yoshimoto M., Kasumi F., Ogata E. What do breast cancer patients benefit from staging bone scintigraphy?. Japanese Journal of Clinical Oncology 2001, 31(6):263-269.
23. Lee J.E., Park S., Han W., Kim S.W., Shin H.J., Choe K.J., et al. The clinical use of staging bone scan in patients with breast carcinoma. Cancer 2005, 104:499-503.
24. Niikura N., Costelloe C.M., Madewell J.E., Hayashi N., Yu T.K., Liu J., et al. FDG-PET/CT Compared with conventional imaging in the Detection of distant metastases of primary breast cancer. The Oncologist 2011, 16(8):1111-1119.
25. Puglisi F., Follador A., Minisini A.M., Cardellino G.G., Russo S., Andreetta C., et al. Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications. Annals of Oncology 2005, 16(2):263-266.
26. Ravaioli A., Tassinari D., Pasini G., Polselli A., Papi M., Fattori P.P., et al. Staging of breast cancer: what standards should be used in research and clinical practice?. Annals of Oncology 1998, 9(11):1173-1177.
27. Schirrmeister H., Kühn T., Guhlmann A., Santjohanser C., Hörster T., Nüssle K., et al. Fluorine-18 2-deoxy-2-fluoro-d-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures. European Journal of Nuclear Medicine and Molecular Imaging 2001, 28(3):351-358.
28. Segaert I., Mottaghy F., Ceyssens S., De Wever W., Stroobants S., Van Ongeval C., et al. Additional value of PET-CT in staging of clinical stage IIB and III breast cancer. The Breast Journal 2010, 16(6):617-624.
29. van der Hoeven J.J.M., et al. 18F-2-fluoro-2-deoxy-d-glucose positron emission tomography in staging of locally advanced breast cancer. Journal of Clinical Oncology 2004, 22(7):1253-1259.
30. Weir L., Worsley D., Bernstein V. The value of FDG positron emission tomography in the management of patients with breast cancer. The Breast Journal 2005, 11(3):204-209.
31. Houssami N., Costelloe C.M. Imaging bone metastases in breast cancer: evidence on comparative test accuracy. Annals of Oncology 2011, 10.1093/annonc/mdr397.
32. Pennant M., Takwoingi Y., Pennant L., Davenport C., Fry-Smith A., Eisinga A., et al. A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence. Health Technol Assess 2010, 14(50):1-103.
33. Reitsma J.B., Rutjes A.W., Khan K.S., Coomarasamy A., Bossuyt P.M. A review of solutions for diagnostic accuracy studies with an imperfect or missing reference standard. Journal of Clinical Epidemiology 2009, 62:797-806.
34. Rojas M.P., Telaro E., Russo A., Moschetti I., Coe L., Fossati R., et al. Follow-up strategies for women treated for early breast cancer. Cochrane Database Systematic Reviews 2000, (4). CD001768.
35. Roselli del Turco M., Palli D., Cariddi A., Ciatto S., Pacini P., Distante V. Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up. JAMA 1994, 271(20):1593-1597.
36. The GIVIO Investigators Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. JAMA 1994, 271(20):1587-1592.